FEXU:LSE First Trust Global Funds Public Limited Company - First Trust US Large Cap Core AlphaDEX UCITS ETF

USD 76.60 -0.92 -1.180417
Icon

First Trust Global Funds Public Limited Company - First Trust US Large Cap Core AlphaDEX UCITS ETF (FEXU:LSE) Stock Analysis and Price Targets

ETF | Others | LSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 76.60

-0.92 (-1.18)%

USD 0.09B

N/A

USD -1.00

N/A

Icon

FEXU:LSE

First Trust Global Funds Public Limited Company - First Trust US Large Cap Core AlphaDEX UCITS ETF (USD)
ETF | LSE
USD 76.60
0.00 0
Take a Tour

First Trust Global Funds Public Limited Company - First Trust US Large Cap Core AlphaDEX UCITS ETF (FEXU:LSE) Stock Forecast

N/A

Based on the First Trust Global Funds Public Limited Company - First Trust US Large Cap Core AlphaDEX UCITS ETF stock forecast from 0 analysts, the average analyst target price for First Trust Global Funds Public Limited Company - First Trust US Large Cap Core AlphaDEX UCITS ETF is not available over the next 12 months. First Trust Global Funds Public Limited Company - First Trust US Large Cap Core AlphaDEX UCITS ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of First Trust Global Funds Public Limited Company - First Trust US Large Cap Core AlphaDEX UCITS ETF is Slightly Bearish, which is based on 1 positive signals and 2 negative signals. At the last closing, First Trust Global Funds Public Limited Company - First Trust US Large Cap Core AlphaDEX UCITS ETF’s stock price was USD 76.60. First Trust Global Funds Public Limited Company - First Trust US Large Cap Core AlphaDEX UCITS ETF’s stock price has changed by -1.32% over the past week, -5.48% over the past month and +18.36% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...